Northwestern Mutual Wealth Management’s Niagen Bioscience NAGE Stock Holding History

Northwestern Mutual Wealth Management’s Portfolio NAGE Stock Details NAGE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-250	Closed	-$1.59K	–	4535
2025 Q4	$1.59K	Buy	+250	New	+$1.74K	﹤0.01%	3540
2025 Q2	–	Sell	-42	Closed	-$290	–	4063
2025 Q1	$290	Buy	+42	New	+$264	﹤0.01%	3425
2022 Q4	–	Sell	-925	Closed	-$1K	–	3495
2022 Q3	$1K	Hold	925	–	–	﹤0.01%	3040
2022 Q2	$2K	Buy	+925	New	+$1.81K	﹤0.01%	2962
2017 Q1	–	Sell	-3,754	Closed	-$12K	–	2455
2016 Q4	$12K	Buy	+3,754	New	+$10.2K	﹤0.01%	1556

Other funds holding NAGE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

SteelPeak Wealth Woodland Hills, California $3.86B AUM 48.92% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

TCM

Tieton Capital Management Yakima, Washington $299M AUM 54.55% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Northwestern Mutual Wealth Management's NAGE Position: Q1 2026 in Review

Northwestern Mutual Wealth Management sold out of Niagen Bioscience (NAGE) in Q1 2026, closing a stake of 250 shares — an estimated $1.59K sold.

Northwestern Mutual Wealth Management first reported a position in NAGE in Q4 2016 and held it in 5 quarters. The position peaked at $12K in Q4 2016. 143 funds tracked by Wall St. Rank hold NAGE as of Q1 2026.

Northwestern Mutual Wealth Management reported no remaining Niagen Bioscience position as of Q1 2026 after selling out during the quarter.
Northwestern Mutual Wealth Management sold 250 Niagen Bioscience shares in Q1 2026, an estimated $1.59K.
Northwestern Mutual Wealth Management first reported a position in Niagen Bioscience in Q4 2016 and held it in 5 quarters.
Northwestern Mutual Wealth Management's Niagen Bioscience position peaked at $12K in Q4 2016.
143 funds tracked by Wall St. Rank held Niagen Bioscience as of Q1 2026.

Based on Northwestern Mutual Wealth Management's 13F filing for Q1 2026, filed 7 May 2026.